Inhibition of angiogenesis by salmosin expressed in vitro.
D020533:Angiogenesis Inhibitors / Q000235:genetics / Q000378:metabolism*; D000818:Animals; D002417:Cattle; D002455:Cell Division / Q000187:drug effects; D002460:Cell Line; D045744:Cell Line, Tumor; D002465:Cell Movement; D002645:Chickens; D002823:Chorion / Q000098:blood supply* / Q000378:metabolism*; D003094:Collagen; D003435:Crotalid Venoms / Q000235:genetics / Q000378:metabolism*; D004338:Drug Combinations; D042783:Endothelial Cells / Q000166:cytology / Q000187:drug effects / Q000378:metabolism; D016222:Fibroblast Growth Factor 2 / Q000494:pharmacology; D015870:Gene Expression; D006801:Humans; D007797:Laminin; D008545:Melanoma / Q000235:genetics / Q000473:pathology; D051379:Mice; D011509:Proteoglycans; D014162:Transfection
D020533:Angiogenesis Inhibitors; D003435:Crotalid Venoms; D004338:Drug Combinations; D007797:Laminin; D011509:Proteoglycans; C115393:salmosin; D016222:Fibroblast Growth Factor 2; C059485:matrigel; D003094:Collagen